Regulation of CDK4

Laurence Bockstaele1, Katia Coulonval, Hugues Kooken

  • 1Institute of Interdisciplinary Research (IRIBHM), Faculté de Médecine, Université Libre de Bruxelles, Campus Erasme, B-1070 Brussels, Belgium. Laurence.Bockstaele@ulb.ac.be

Cell Division
|November 10, 2006
PubMed

Insights

Cyclin-dependent kinase 4 (CDK4) activation is key to cell cycle control and cancer. New findings highlight T-loop phosphorylation as a critical, yet debated, regulatory step for CDK4, impacting its role in cell cycle progression.

Area of Science:

  • Molecular biology
  • Cell cycle regulation
  • Cancer research

Background:

  • Cyclin-dependent kinase 4 (CDK4) integrates extracellular signals to regulate the cell cycle.
  • CDK4 plays a significant role in oncogenic transformation processes.
  • Key aspects of CDK4 activation, including cyclin D association, subcellular localization, and Thr172-phosphorylation, are not fully understood.

Purpose of the Study:

  • To review and clarify poorly understood molecular features of CDK4 activation.
  • To discuss the role of Cip/Kip CDK inhibitors in CDK4 regulation.
  • To present recent findings on T-loop phosphorylation as a critical regulatory mechanism for CDK4.

Main Methods:

  • Literature review of CDK4 activation mechanisms.
  • Analysis of molecular features regulating CDK4 function.
  • Recent experimental identification of T-loop phosphorylation in CDK4.

Main Results:

  • CDK4 activation involves complex regulation of its association with D-type cyclins and subcellular localization.
  • The activating Thr172-phosphorylation of CDK4 is a critical target for cell cycle control.
  • T-loop phosphorylation of CDK4, unlike CDK6, is identified as a determining factor for cell cycle control by extracellular signals.

Conclusions:

  • The regulation of CDK4 activation is multifaceted, involving cyclin binding, localization, and phosphorylation.
  • Recent findings suggest that the kinases responsible for CDK4 activation may require re-evaluation.
  • Understanding these regulatory mechanisms is crucial for targeting CDK4 in cancer therapy.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...